The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nexium Control

GlaxoSmithKline Dungarvan LimitedEU/1/13/860/003

Main Information

Trade NameNexium Control
Active SubstancesEsomeprazole magnesium trihydrate
Dosage FormGastro-resistant capsule, hard
Licence HolderGlaxoSmithKline Dungarvan Limited
Licence NumberEU/1/13/860/003

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC05 esomeprazole


License statusAuthorised
Licence Issued
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back